Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

11.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Pharmacokinetic Simulation Help Improve Management of Unfractionated Heparin Therapy?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Pathogen reduction diminishes the protective effects of platelets on endothelial barrier permeability in vitro.

Blood vessels, thrombosis & hemostasis·2025
Same author

Old Tool-New Use.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2025
Same author

Iron Deficiency in the PICU: An Invisible Illness?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024
Same author

The BASIC Bleeding Score: Does It Teach Us More Than Just How to Rate Bleeding?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024
Same author

Balancing Pharmacologic Anticoagulation in Extracorporeal Membrane Oxygenation: Is It Now Time to Follow the Path Less Taken?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024

Related Experiment Video

Updated: Nov 20, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.2K

Hemostatic Testing in Critically Ill Infants and Children.

Alison B Nair1, Robert I Parker2

  • 1Pediatric Critical Care Medicine, University of California, San Francisco, San Francisco, CA, United States.

Frontiers in Pediatrics
|January 25, 2021
PubMed
Summary

Critically ill children often have hemostasis imbalances. Newer whole blood assays offer a global assessment of clot formation and fibrinolysis, improving diagnosis over traditional plasma tests.

Keywords:
coagulopathydevelopmental hemostasisdiagnosispediatricviscoelastic

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.3K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.0K

Related Experiment Videos

Last Updated: Nov 20, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.2K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.3K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.0K

Area of Science:

  • Pediatric critical care medicine
  • Hemostasis and thrombosis research
  • Clinical pathology

Background:

  • Children with critical illness often experience hemostasis dysregulation, increasing risks of bleeding or thrombosis.
  • Traditional plasma-based clot formation tests have limitations in assessing fibrinolysis, platelet function, and endothelial cell roles.
  • Lower protein levels in pediatric patients can skew traditional test results, complicating hemostasis assessment.

Purpose of the Study:

  • To review the mechanisms of clot formation and hemostasis regulation.
  • To evaluate the limitations of traditional coagulation tests in critically ill children.
  • To discuss newer hemostasis assays and their comparison to conventional methods.

Main Methods:

  • Review of existing literature on hemostasis testing in pediatric critical care.
  • Analysis of traditional plasma-based coagulation assays.
  • Discussion of newer whole blood viscoelastic and thrombin generation assays.

Main Results:

  • Traditional tests are insensitive to fibrinolysis and platelet/endothelial cell contributions.
  • Pediatric-specific factors affect traditional test interpretation.
  • Newer assays provide a more global assessment of the hemostatic system.

Conclusions:

  • Newer hemostasis assays offer advantages over traditional tests for critically ill children.
  • Advanced assays may improve the assessment and management of hemostatic disorders in this population.
  • Comprehensive evaluation using newer methods is crucial for pediatric critical care.